CClinicalTrials.gg
Status unknownNCT03287648Updated Jan 20, 2021

Simultaneous OCT and B-FAF in Eyes With Alteration of the Foveal Contour

An observational study in Lamellar Macular Hole and Lamellar Macular Pseudohole, sponsored by University of Molise. Status unknown at 1 site in Italy. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-01-20.

Sponsored by University of Molise · Observational

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
20
Ages
20 Years to 90 Years
Sex
All
01

Study summary

Some alterations of the foveal contour do not meet the criteria established for the definition of lamellar macular hole on the basis of optical coherence tomography (OCT). However, these alterations may show an appearance, on blue fundus autofluorescence (B-FAF) imaging, reminiscent of lamellar macular hole.

The aim of the study is to evaluate in detail these alterations recording simultaneously OCT and B-FAF.

Read the detailed description

All images will be collected using the Heidelberg Spectralis system (Heidelberg Engineering, Heidelberg, Germany) according to the prespecified imaging protocols. Blue-fundus autofluorescence (excitation wavelength at 488 nm and barrier filter at 500 nm) images and SD-OCT images will be obtained after pupil dilation.

The OCT recording protocol will consist of a sequence of 37 horizontal sections, spaced 120-µm apart, covering an area of 20° or 30° horizontally by 15° vertically, and a sequence of 24 radial sections recorded in the high-resolution (HR) mode simultaneously with infrared (IR) images.

In addition, simultaneous B-FAF/OCT images will be acquired (horizontal, and vertical OCT sections, centered on the fovea and recorded in the HR mode).

The same OCT/FAF protocol will be used for the study eye and for the fellow eye.

For the study eyes that had been examined in the past, the ''Follow-up'' function will be used in addition to the prespecified protocol to evaluate if any changes had occurred since the last scan.

Multiple other morphological characteristics will be analyzed using OCT imaging, including the status of the posterior cortex, the presence of operculum, the integrity/disruption of the external limiting membrane (ELM), ellipsoid zone (EZ), and the central and minimal foveal thickness (CFT and mFT respectively). The latter will be defined as the thinnest part of the fovea within the foveal pit identified by examining radial scans whereas the former will be measured in relation to the highest point of the foveal bulge.

All measurements will be performed using the Spectralis built-in manual caliper function at high magnification after adjusting the scale to 1:1 µm except for CFT, which will be calculated using the automated ''thickness map'' function of the Heidelberg Eye Explorer.

02

Conditions studied

  • Lamellar Macular Hole
  • Lamellar Macular Pseudohole

Browse trials for

Keywords

  • optical coherence tomography
  • blue fundus autofluorescence
03

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

outpatients affected by alteration of the foveal contour associated with increased autofluorescence signal at the fovea

Inclusion criteria

  • alteration of the foveal contour not classifiable as lamellar or pseudo macular hole
  • focal, well-defined increased autofluorescence signal at the fovea

Exclusion criteria

Exclusion Criteria:

  • intraretinal cysts not associated with break of the inner retina
  • juxtafoveal telangiectasia
  • ring of increased B-FAF
  • vitelliform and pseudovitelliform lesions
  • history of diabetes, retinal vein occlusion, uveitis, CSR, AMD or any other retinal -disease potentially associated with intra or subretinal fluid
  • macular drusen
  • history of submacular hemorrhage
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
20 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testoptical coherence tomography and blue-fundus autofluorescence

    Simultaneous infra-red and optical coherence tomography (cube and radial pattern) centered on the fovea Simultaneous fundus autofluorescence and optical coherence tomography (radial pattern) centered on the fovea

    Also known as: infra-red, color pictures

05

What researchers measure

Primary outcomes

  1. Relationship between OCT and B-FAF findings

    Measurements of the diameters of the holes expressed in microns, on OCT and B-FAF images respectively, will be collected. The topographic correlation between the area of increased B-FAF signal and the corresponding area on OCT, will be examined.

    Time frame: 6 months

Secondary outcomes

  1. Relationship between OCT and B-FAF characteristics and logMAR visual acuity

    The relationship between central foveal thickness and logMAR visual acuity will be evaluated

    Time frame: 6 months

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03287648
Lead sponsor
University of Molise
Collaborators
University of Milan
Responsible party
Roberto dell'Omo (Associate Professor, University of Molise) — Principal investigator
First posted
Sep 19, 2017
Start date
Jun 1, 2017
Primary completion
Jan 15, 2021
Completion
May 20, 2024 (estimated)
Last update
Jan 20, 2021

Study contacts

Roberto dell'Omo, Prof
Contact
roberto.dellomo@unimol.it
00393317120416
Ciro Costagliola, Prof
Contact
ciro.costagliola@unimol.it
00393683589790

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion